id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S15393 R63458 |
Noh, 2022 | Overall major congenital malformations | 1st trimester | population based cohort retrospective | unexposed, sick | Adjustment: Yes BZD Coexposure: Not specified | 1.50 [1.06;2.11] | 30/381 156,896/3,053,381 | 156,926 | 381 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15450 R63542 |
Czeizel, 2004 | Major congenital anomalies | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: Yes BZD Coexposure: Yes (with psychiatric (ATD and/or psychotropics) medications) Matched | 1.50 [1.00;2.30] | -/- 22,874/- | - | - |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15425 R63496 |
Bracken, 1981 | Major congenital malformations | 1st trimester | case control | unexposed (general population or NOS) | Adjustment: No BZD Coexposure: Not specified Indication BZD: Psychiatric diseases (depression, anxiety, ...) | 1.81 [0.55;5.94] C | 5/11 1,365/4,327 | 1,370 | 11 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S15662 R64676 |
Kullander, 1976 | Major malformations (gross and insignificant major malfo) | 1st trimester | nested case control | unexposed (general population or NOS) | Adjustment: No BZD Coexposure: Not specified | 0.61 [0.15;2.48] C | 2/84 198/5,118 | 200 | 84 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 4 studies | 1.47 [1.14;1.89] | 158,496 | 476 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
Asymetry test p-value = NaN (by Egger's regression)
not enought points
excluded